Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 3Thoracic 1Head & Neck 1

Conditions

Squamous Cell Carcinoma of Head and Neck 88Head and Neck Neoplasms 42Carcinoma, Non-Small-Cell Lung 32Melanoma 27Carcinoma, Renal Cell 24Colorectal Neoplasms 18Carcinoma, Transitional Cell 16Carcinoma, Hepatocellular 14Ovarian Neoplasms 13Neoplasm Metastasis 13Carcinoma, Squamous Cell 13Triple Negative Breast Neoplasms 11Stomach Neoplasms 11Carcinoma, Merkel Cell 11Uterine Cervical Neoplasms 10Pancreatic Neoplasms 10Nasopharyngeal Carcinoma 10Oropharyngeal Neoplasms 8Thyroid Neoplasms 7Urinary Bladder Neoplasms 6Small Cell Lung Carcinoma 6Sarcoma 6Recurrence 6Breast Neoplasms 6Mouth Neoplasms 5Lymphoma 5Lung Neoplasms 5Esophageal Neoplasms 5Endometrial Neoplasms 5Salivary Gland Neoplasms 4

Interventions

spartalizumab 1Oxaliplatin 1Nivolumab 1Leucovorin 1Fluorouracil 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Spinocerebellar Degenerations × Nivolumab × Head & Neck × Clear all
NCT06544655 2026-04-17

A Study of BMS-986484 Alone and Combination Therapy in Participants With Advanced Solid Tumors

Bristol-Myers Squibb

Phase 1 Active not recruiting
213 enrolled
GastrointestinalHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Spinocerebellar Degenerations, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡